257 related articles for article (PubMed ID: 1596892)
1. Activation of the Ha-, Ki-, and N-ras genes in chemically induced liver tumors from CD-1 mice.
Manam S; Storer RD; Prahalada S; Leander KR; Kraynak AR; Ledwith BJ; van Zwieten MJ; Bradley MO; Nichols WW
Cancer Res; 1992 Jun; 52(12):3347-52. PubMed ID: 1596892
[TBL] [Abstract][Full Text] [Related]
2. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
3. [Mutations in the 61st codon of the c-Ki-ras oncogene during transplacental lung tumor induction in mice and their difference in spontaneous and induced tumors].
Loktionov AS
Mol Biol (Mosk); 1991; 25(6):1517-25. PubMed ID: 1813798
[TBL] [Abstract][Full Text] [Related]
4. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride.
Froment O; Boivin S; Barbin A; Bancel B; Trepo C; Marion MJ
Cancer Res; 1994 Oct; 54(20):5340-5. PubMed ID: 7923162
[TBL] [Abstract][Full Text] [Related]
5. ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3H/HeJ and (C3H x A/J)F1 mice.
Wang Y; Wang Y; Stoner G; You M
Cancer Res; 1993 Apr; 53(7):1620-4. PubMed ID: 8453632
[TBL] [Abstract][Full Text] [Related]
6. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
7. Dose-related changes in the profile of ras mutations in chemically induced CD-1 mouse liver tumors.
Manam S; Shinder GA; Joslyn DJ; Kraynak AR; Hammermeister CL; Leander KR; Ledwith BJ; Prahalada S; van Zwieten MJ; Nichols WW
Carcinogenesis; 1995 May; 16(5):1113-9. PubMed ID: 7767973
[TBL] [Abstract][Full Text] [Related]
8. Differential selection for B-raf and Ha-ras mutated liver tumors in mice with high and low susceptibility to hepatocarcinogenesis.
Buchmann A; Karcier Z; Schmid B; Strathmann J; Schwarz M
Mutat Res; 2008 Feb; 638(1-2):66-74. PubMed ID: 17928010
[TBL] [Abstract][Full Text] [Related]
9. Activation of H-ras oncogenes in preneoplastic mouse mammary tissues.
Kumar R; Medina D; Sukumar S
Oncogene; 1990 Aug; 5(8):1271-7. PubMed ID: 2118247
[TBL] [Abstract][Full Text] [Related]
10. Incidence of mutations at codon 61 of the Ha-ras gene in liver tumors of mice genetically susceptible and resistant to hepatocarcinogenesis.
Dragani TA; Manenti G; Colombo BM; Falvella FS; Gariboldi M; Pierotti MA; Della Porta G
Oncogene; 1991 Feb; 6(2):333-8. PubMed ID: 2000226
[TBL] [Abstract][Full Text] [Related]
11. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice.
Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW
Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158
[TBL] [Abstract][Full Text] [Related]
12. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
[TBL] [Abstract][Full Text] [Related]
13. Cell-type-specific ras mutations but no microsatellite instability in chemically induced mouse skin tumors and transformed 3T3 cells.
Sasaki K; Bertrand O; Nakazawa H; Fitzgerald DJ; Mironov N; Yamasaki H
Cancer Res; 1995 Aug; 55(16):3513-6. PubMed ID: 7627957
[TBL] [Abstract][Full Text] [Related]
14. Rapid induction of skin tumors in human but not mouse c-Ha-ras proto-oncogene transgenic mice by chemical carcinogenesis.
Muto S; Katsuki M; Horie S
Cancer Sci; 2006 Sep; 97(9):842-7. PubMed ID: 16805855
[TBL] [Abstract][Full Text] [Related]
15. Activation of the Ki-ras gene in spontaneous and chemically induced lung tumors in CD-1 mice.
Manam S; Storer RD; Prahalada S; Leander KR; Kraynak AR; Hammermeister CL; Joslyn DJ; Ledwith BJ; van Zwieten MJ; Bradley MO
Mol Carcinog; 1992; 6(1):68-75. PubMed ID: 1503645
[TBL] [Abstract][Full Text] [Related]
16. N-ras mutation in ultraviolet radiation-induced murine skin cancers.
Pierceall WE; Kripke ML; Ananthaswamy HN
Cancer Res; 1992 Jul; 52(14):3946-51. PubMed ID: 1617670
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous and thiazolidinedione-induced B6C3F1 mouse hemangiosarcomas exhibit low ras oncogene mutation frequencies.
Duddy SK; Gorospe SM; Bleavins MR; de la Iglesia FA
Toxicol Appl Pharmacol; 1999 Oct; 160(2):133-40. PubMed ID: 10527912
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of the H-ras oncogene in spontaneous C57BL/6 x C3H/He mouse liver tumors and tumors induced with genotoxic and nongenotoxic hepatocarcinogens.
Fox TR; Schumann AM; Watanabe PG; Yano BL; Maher VM; McCormick JJ
Cancer Res; 1990 Jul; 50(13):4014-9. PubMed ID: 2191770
[TBL] [Abstract][Full Text] [Related]
19. [Activation of the Ha-ras oncogene in tumors induced in mice by transplacental exposure to 7,12-dimethylbenz(a)anthracene].
Loktionov AS; Hollstein M; Martel N; Galendo D; Tomatis L; Yamasaki H
Vopr Onkol; 1991; 37(3):297-303. PubMed ID: 1903226
[TBL] [Abstract][Full Text] [Related]
20. Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas.
Kito K; Kihana T; Sugita A; Murao S; Akehi S; Sato M; Tachibana M; Kimura S; Ueda N
Mol Carcinog; 1996 Oct; 17(2):78-83. PubMed ID: 8890956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]